These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2140392)

  • 1. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I.
    Ekdahl KN; Nilsson UR; Nilsson B
    J Immunol; 1990 Jun; 144(11):4269-74. PubMed ID: 2140392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
    Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
    J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.
    Seya T; Nagasawa S
    J Biochem; 1985 Jan; 97(1):373-82. PubMed ID: 3158646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
    Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells.
    Scheiner O; Schulz TF; Schmid HU; Lambris JD; Alsenz J; Dierich MP
    Immunobiology; 1983 Aug; 165(2):211-24. PubMed ID: 6226591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
    Fries LF; Prince GM; Gaither TA; Frank MM
    J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
    Ezzell JL; Parker CJ
    Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase. Inhibition of factor I-mediated cleavage of C3b.
    Ekdahl KN; Nilsson B
    J Immunol; 1995 Jun; 154(12):6502-10. PubMed ID: 7539023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
    Alsenz J; Lambris JD; Schulz TF; Dierich MP
    Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T; Lavoie S; Nussenzweig V
    J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
    Fries LF; Gaither TA; Hammer CH; Frank MM
    J Exp Med; 1984 Dec; 160(6):1640-55. PubMed ID: 6239898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
    Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
    J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
    Cunnion KM; Hair PS; Buescher ES
    Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.